NUTEX.BUD Nutex Investments PLC

Healthcare Pharmaceuticals Budapest Stock Exchange
12.40 HUF
Close of Oct 29, 2026
11.90 17.00
Market cap
HUF 2.12B
P/E
2.0x
P/B
0.34x
ROE
9.0%
Dividend yield
-
Fundamental score
2.1/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is NUTEX.BUD undervalued?

Graham number

The Graham number of Nutex Investments PLC cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nutex Investments PLC fundamental analysis

11 of 22 checks passed

ROE 0/2

Low return on equity (8.1%), below 10%.

ROA 1/1

Return on assets (8.1%) is above the industry median (3.8%).

Profit Consistency 2/2

Profitable for 6 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (16.7%) is not above the 5-year average (67.8% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (16.7%) is above the industry median (14.7%).

Revenue Growth 0/2

Revenue shrank 0.0% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 0/1

No interest expense reported.

PE vs Market 1/1

PE (2.0x) is below the market median (9.7x).

PE vs Industry 1/1

PE (2.0x) is below the industry median (16.6x).

PBV 1/1

Price to book (0.3x) is below the industry median (1.5x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 0.7, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.03, growth is cheap.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Nutex Investments PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nutex Investments PLC

NUTEX Investments Public Limited Company provides health preserving, health promotion, nutritional supplement, and cosmetic products in Hungary and internationally. It also engages in asset management. The company was formerly known as HUMET Trade, Research and Development Public Limited Company and changed its name to NUTEX Investments Public Limited Company in February 2011. The company was incorporated in 1996 and is based in Budapest, Hungary.

Full company profile